Agreements, Acquisitions, and Expansions Accounted for the Largest Share of the Overall Growth Strategies Followed by Key Players in the Creatinine Assay Kits Market Between 2014 and 2017.
Increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders are driving the growth of the global creatinine assay kits market
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73499229
The global creatinine assay kits market is expected to reach USD 245.4 Million by 2022 from USD 189.6 Million in 2017, at a CAGR of 5.3%.
Key Players
Prominent players in this market include Thermo Fisher Scientific (US), Merck (Germany), Abbott Laboratories (US), Abcam (UK), Quidel (US), Enzo Life Sciences (US), Cayman Chemical (US), Cell Biolabs (US), Genway Biotech (US), BioAssay Systems (US), Wako Pure Chemical Industries (Japan), Tulip Diagnostics (India), BioVision (US), and Arbor Assays (US)
Thermo Fisher Scientific was the leading player in the creatinine assay kits market in 2016.
The leading position of the company can be attributed to its strong brand recognition, customer loyalty, and extensive product portfolio. The company has a strong geographic presence and a keen focus on increasing its reach and enhancing its distribution network. Along with its wide distribution network, the company also adopts strategies like collaborations and agreements to retain its market position.
Merck KGaA ranked second in the creatinine assay kits market in 2016.
The company has strong brand recognition and a wide geographical presence. The company prominently focuses on inorganic growth strategies such as agreements, collaborations, and acquisitions to strengthen its market position. It acquired Sigma-Aldrich (US), a multinational chemical, life science, and biotechnology company, for USD 17 billion.
To Know More @ https://www.marketsandmarkets.com/Market-Reports/creatinine-assay-kits-market-73499229.html
